TP53 and cancer: Ellipticine and 9-hydroxyellipticine also cause selective inhibition of p53 protein phosphorylation in several human cancer cell lines (Ohashi et al., 1995; Sugikawa et al., 1999) and this correlates with their cytotoxic activity.